News Releases

2010
2009
2008
2007
2006
2005
2004

 

   
  December 21, 2007 Protox Announces Stock Options Granted
  November 27, 2007 Protox Releases Q3 2007 Financial Results And Company Highlights
  November 20, 2007 Protox Receives $7.6 Million From Exercise Of Warrants
  November 14, 2007 Protox Collaborates With Brainlab For Brain Cancer Program
  November 1, 2007 Protox Announces Positive Final Data From Prostate Cancer Study
  October 31, 2007 Protox To Present At Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
  October 26, 2007 Protox Receives $5.2 Million To Date From Exercise Of Warrants
  October 25, 2007 Protox Modifies Terms Of Share Purchase Warrants
  October 22, 2007 Protox Appoints Dr. Samuel Denmeade as Chief Scientific Officer
  October 18, 2007 Protox Strengthens Patent Portfolio And Protection Of PRX302
  October 3, 2007 Protox Completes BPH Trial Recruitment And Announces Positive Interim Data
  September 18, 2007 Protox Appoints Dr. Martin Gleave as Chair of Clinical Advisory Board
  September 17, 2007 Protox to Present at the Admetech Foundation Conference
  September 07, 2007 Protox To Present Interim Prostate Cancer Data At AUA Conference
  August 30, 2007 Protox Releases Q2 2007 Financial Results And Company Highlights
  August 21, 2007 Protox Acquires Research Program From Medicenna
  July 17 , 2007 Protox Announces Manufacturing Agreement With Dompe For PRX321
  July 10 , 2007 Protox Announces Positive Clinical Data From Prostate Cancer Study
  June 06 , 2007 Protox completes prostate cancer trial recruitment
  May 17 , 2007 Protox releases Q1 2007 financial results and company highlights
  May 08 , 2007 Protox to present at Bio 2007
  Apr 27, 2007 Protox reports 2006 financial results and achievements
  Apr 24, 2007 Protox doses first patient in benign prostatic
hyperplasia trial using PRX302
Apr 24, 2007 Protox to present at BioFinance 2007
Mar 28, 2007 Protox initiates Phase 1 Study of PRX302 for Benign Prostatic Hyperplasia
Mar 26, 2007 Protox Announces Senior Management Changes
Mar 20, 2007 Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
Mar 8, 2007 Protox Therapeutics to Present at BioSquare 2007
Mar 1, 2007 Protox Outlines Milestones for 2007
Feb 23, 2007 Protox Announces PRX302 Data to be Presented at ASCO Sponsored Prostate Cancer Symposium
Feb 22, 2007 Protox Anounces Stock Options Granted
Feb 9, 2007 Protox Anounces Addition to Management Team
Jan 18, 2007 Protox Reports Promising Interim Results From Prostate Cancer Study
Jan 17, 2007 Protox Therapeutics Notice of Conference Call and Webcast

What's New

June 2 2010
Protox Announces Positive Six Month Phase 2B BPH Results

June 1, 2010
Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association

May 13, 2010
Protox Reports First Quarter 2010 Financial Results

April 29, 2010
Protox Signs $75 Million License Agreement with Kissei for Commercialization of PRX302 in Japan for BPH and Prostate Disease

 

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

 

Stock Quote

LAST TRADE:$0.39
TRADE TIME:3:53PM EST
CHANGE:$0.00 (0.00%)
PREV CLOSE: $0.39
OPEN:$0.39
BID:$0.385
ASK:$0.39